Table 2.
Characteristics | n = 35 | Local control | Overall survival | ||
---|---|---|---|---|---|
3‐year (%) | P value | 3‐year (%) | P value | ||
Age | |||||
≧59 | 18 | 93 | 0.45 | 83 | 0.26 |
<59 | 17 | 94 | 93 | ||
Sex | |||||
Male | 15 | 94 | 0.85 | 93 | 0.34 |
Female | 20 | 92 | 84 | ||
Performance status | |||||
0 | 11 | 91 | 0.69 | 100 | 0.05 |
1/2 | 24 | 94 | 82 | ||
Histology | |||||
Adenoid cystic carcinoma | 21 | 90 | 0.64 | 90 | 0.66 |
Olfactory neuroblastoma | 5 | 100 | 100 | ||
Mucoepidermoid carcinoma | 4 | 100 | 67 | ||
Adenocarcinoma | 2 | 100 | – | ||
Others | 3 | 100 | 67 | ||
Location of primary tumor | |||||
Maxillary sinus/nasal cavity | 18 | 93 | 0.17 | 88 | <0.01 |
Oral cavity/pharynx | 9 | 100 | 100 | ||
Parotid gland | 6 | 83 | 100 | ||
External auditory canal | 2 | – | 0 | ||
Operability | |||||
Operable | 15 | 93 | 0.85 | 80 | 0.14 |
Inoperable | 20 | 93 | 95 | ||
Disease | |||||
Primary tumor | 29 | 92 | 0.74 | 89 | 0.24 |
Postoperative recurrence | 6 | 100 | 83 | ||
T stage | |||||
T2 | 5 | 100 | 0.08 | 100 | 0.95 |
T3 | 8 | 86 | 88 | ||
T4 | 22 | 94 | 85 | ||
Radiation dose | |||||
64.0 Gy (RBE)/16 fractions | 32 | 93 | 0.39 | 100 | 0.47 |
57.6 Gy (RBE)/16 fractions | 3 | 100 | 87 |